Literature DB >> 25054769

Porphyria cutanea tarda and Sjogren's syndrome.

Su Fang1, XiaoJie Sun1, ZanFeng Wang2, DanYang Song1, TieNan Li1.   

Abstract

Porphyria cutanea tarda is prevalent in connective tissue disease, common in systemic lupus erythematosus. However, the co-existence of primary sjogren's syndrome and porphyria cutanea tarda is rare and poses diagnostic and therapeutic challenges. We report a case of porphyria cutanea tarda associated with primary sjogren's syndrome.

Entities:  

Mesh：

Year:  2014        PMID： 25054769      PMCID： PMC4148296          DOI： 10.1590/abd1806-4841.20142969

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


  7 in total

1.  Subacute systemic lupus erythematosus: porphyria.

Authors:  I B SNEDDON
Journal:  Br J Dermatol       Date:  1962-04       Impact factor: 9.302

2.  [Colic caused by porphyrin; symptomatology of the acute erythematodes].

Authors:  S WOLFRAM
Journal:  Hautarzt       Date:  1952-07       Impact factor: 0.751

3.  Coexistence of lupus erythematosus and porphyria cutanea tarda in fifteen patients.

Authors:  G E Gibson; M T McEvoy
Journal:  J Am Acad Dermatol       Date:  1998-04       Impact factor: 11.527

4.  Coexistence of porphyria cutanea tarda and systemic lupus erythematosus.

Authors:  G D Nicholson; P R Prussia; S Garriques
Journal:  West Indian Med J       Date:  1988-12       Impact factor: 0.171

5.  Porphyria cutanea tarda in association with Sjögren's syndrome.

Authors:  R Ramasamy; M M Kubik
Journal:  Practitioner       Date:  1982-07

Review 6.  Increased photosensitivity? Case report of porphyria cutanea tarda associated with systemic lupus erythematosus.

Authors:  Scheila Fritsch; Adma Silva de Lima Wojcik; Lilian Schade; Milton Marcio Machota Junior; Fabiane Mulinari Brenner; Eduardo dos Santos Paiva
Journal:  Rev Bras Reumatol       Date:  2012-12

7.  Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda.

Authors:  C L Thomas; M N Badminton; J R S Rendall; A V Anstey
Journal:  Clin Exp Dermatol       Date:  2008-05-21       Impact factor: 3.470
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.